Skip to main content
2026 AAOMS 108th Annual Meeting Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Ticketed <br><i>This session/event requires a ticket.</i>
Ticketed
This session/event requires a ticket.
In-person only<br><i>This session is offered in-person only.</i>
In-person only
This session is offered in-person only.
On-demand<br><i>On-demand session available beginning Sept. 28.</i>
On-demand
On-demand session available beginning Sept. 28.
Recorded<br><i>This session will be recorded and available beginning Oct. 19</i>
Recorded
This session will be recorded and available beginning Oct. 19
Sold Out<br><i>This ticketed session/event is sold out.</i>
Sold Out
This ticketed session/event is sold out.

Glenn J. Hanna, MD (he/him/his)

Director, Center for Cancer Therapeutic Innovation
Dana-Farber Cancer Institute
Boston, Massachusetts

Dr. Hanna completed his fellowship training in medical oncology at Dana-Farber Cancer Institute in 2016. Prior to this, he earned his medical degree from Georgetown University School of Medicine in 2010, where he graduated summa cum laude. He joined the faculty of the Center for Head and Neck Oncology in 2017. Dr. Hanna is the Director of the Center for Cancer Therapeutic Innovation (CCTI), the early drug development program at DFCI and an Associate Professor of Medicine at Harvard Medical School. His clinical and translational research efforts focus on precision medicine and novel approaches to treat head and neck cancers.

Presentation(s):